JournalTechnology readiness

TRL-adjusted discount rates: pricing risk in early-stage technology valuation

Technology valuation discount rate explained: how TRL changes the rate, a worked rupee DCF and risk-adjusted NPV, and how to defend your numbers to a buyer.

By Sahil Sheikh, Regd. Patent & Trademark Agent, cRTTP 8 min read

Part of the guide TRL levels explained: what TRL 1 to 9 really mean, and how to place your technology

Short answer

A TRL-adjusted discount rate raises the discount rate in a cash flow valuation as technology readiness falls, because immature technology fails more often. In our illustration, the same ₹530 lakh of forecast cash is worth ₹103 lakh at 25%, ₹35 lakh at 40% and below zero at 60%. Risk-adjusted NPV reaches similar values using explicit success probabilities.

Every income-based valuation of a technology ends with one number that moves the answer more than any other: the discount rate. Change it from 25% to 40% and the value of a lab technology can fall by two-thirds. Yet in most valuation reports I review, the rate gets one sentence and no reasoning.

Technology readiness level is the most useful single anchor I know for that rate. This post shows why, how to build a TRL-adjusted rate, how risk-adjusted NPV does the same job more transparently, and a worked rupee example of both. It assumes you know the basics of discounted cash flow; if not, start with our guide to patent valuation for startups.

Why should readiness change the discount rate?

A discount rate does two jobs. It accounts for the time value of money, and it charges for the chance that the forecast cash never arrives. For a mature product the second job is small. For a technology at TRL 3, it is most of the work.

Readiness is a direct measure of that chance. India's National Technology Readiness Assessment Framework (NTRAF) groups the nine levels into three bands in its screening step: proof of concept (TRL 1 to 3), prototype development (TRL 4 to 6) and manufacturing and commercialisation (TRL 7 to 9). A technology in the first band still has to show that it works at all. One in the last band mostly has to show that it sells.

So the same forecast deserves a higher rate at TRL 3 than at TRL 7. That much is uncontroversial. The hard part is how much higher.

Is there a standard TRL discount rate table?

Not one I can point you to. I have not found an Indian regulator, valuation standard or funding agency that publishes discount rates by TRL, and I would be wary of anyone who quotes one as a market rule. Valuers build the rate themselves, usually from a cost of capital plus a premium for specific risk.

What follows is the table I use as a starting point in examples and negotiations. It is an illustrative assumption, not a market standard. Treat it as a frame for your own reasoning.

NTRAF band TRL What still has to be proven Illustrative discount rate
Proof of concept 1 to 3 That the core effect works and can be controlled 50% or more
Prototype development 4 to 6 That it works outside ideal lab conditions and can be built 30% to 50%
Manufacturing and commercialisation 7 to 9 That it can be made reliably and sold 15% to 30%

Within each band, adjust for the things TRL does not measure: a regulated product (a diagnostic or a drug) carries approval risk on top of technical risk, a pending patent carries grant risk, and a first-of-kind market carries adoption risk.

Illustrative discount rate falls as readiness rises

TRL 7-9Commercialisation: 15% to 30%
TRL 4-6Prototype development: 30% to 50%
TRL 1-3Proof of concept: 50% or more
Illustrative assumptions for examples, not a market standard.

A worked example: one forecast, several rates

Illustration with invented figures. A startup has a process technology at TRL 4. It needs ₹40 lakh of development in year 1 and ₹60 lakh in year 2 to reach a pilot, then expects net cash flows from year 3 as sales build. All amounts are in ₹ lakh, received at year end.

Year Net cash flow (₹ lakh) Discount factor at 40% Present value (₹ lakh)
1 −40 0.7143 −28.57
2 −60 0.5102 −30.61
3 30 0.3644 10.93
4 80 0.2603 20.82
5 120 0.1859 22.31
6 140 0.1328 18.59
7 140 0.0949 13.28
8 120 0.0678 8.13
Total 530 34.89

At 40%, in the middle of the illustrative TRL 4 to 6 band, the technology is worth about ₹34.9 lakh today, against ₹530 lakh of undiscounted net cash.

Now run the same forecast at other rates.

Discount rate Roughly fits Value today (₹ lakh)
15% A mature, low-risk business 197.36
25% TRL 7 to 9 103.24
35% Upper TRL 4 to 6 51.62
45% Lower TRL 4 to 6 22.13
60% TRL 1 to 3 −1.11

The pattern is the point. Moving the technology from TRL 4 to TRL 7, with no change at all to the forecast, roughly triples its value in this example. That is why companies pay much more for a validated pilot than for a lab result, and why every rupee spent climbing the scale before licensing can pay back several times over.

At 60%, the value turns slightly negative. The early development costs are discounted lightly, and the income years later is discounted heavily. A buyer valuing a TRL 2 technology this way will offer little upfront and push the price into milestones, which is the right structure; see milestone payments in technology licenses.

Risk-adjusted NPV: the same answer, with the risk visible

A single high rate hides where the risk sits. Risk-adjusted NPV (rNPV) separates the two jobs. You discount at a base rate that reflects the time value of money and ordinary business risk, and you multiply each year's cash flow by the probability that the project is still alive in that year.

Same illustration. Base rate 15%. Year 1 spending happens for certain. There is a 60% chance the year 1 work succeeds and year 2 spending goes ahead, and a 35% chance the technology reaches launch and earns from year 3. These probabilities are invented.

Year Net cash flow (₹ lakh) Probability Discount factor at 15% Present value (₹ lakh)
1 −40 1.00 0.8696 −34.78
2 −60 0.60 0.7561 −27.22
3 30 0.35 0.6575 6.90
4 80 0.35 0.5718 16.01
5 120 0.35 0.4972 20.88
6 140 0.35 0.4323 21.18
7 140 0.35 0.3759 18.42
8 120 0.35 0.3269 13.73
Total 35.13

The rNPV is about ₹35.1 lakh, almost exactly the ₹34.9 lakh from a single 40% rate. That is no coincidence: I chose the probabilities to show that a 40% rate on this forecast implies roughly a one-in-three chance of reaching market. Working backwards like this is the best test I know of whether a discount rate is sensible. If you cannot believe the success probability your rate implies, the rate is wrong.

Two ways to price early-stage risk

Risk-adjusted rate
One high rate on the full forecast
Easy to explain in one line
Hides which stage carries the risk
vs
Risk-adjusted NPV
Base rate plus stage probabilities
Shows where failure is likely
Needs probabilities you can defend

Use rNPV to reason, then quote the implied single rate.

How do you choose the probabilities?

Here TRL is again the anchor. Each step up the scale is a gate the project may fail. A practical way to set probabilities:

  1. Assess the current TRL honestly, against the evidence each level needs. How to prove your TRL lists what reviewers expect.
  2. List the gates between now and first sale: for example TRL 4 to 6, pilot scale, regulatory approval, first customer.
  3. Give each gate a probability of passing, and write one sentence on why.
  4. Multiply them to get the cumulative probability in each year.

Be modest with your numbers. Founders tend to give every gate 80% or 90%, and four such gates still leave a combined chance of only 41% to 66%, which surprises them. A buyer will do this arithmetic whether you do or not.

How buyers and licensors use this in negotiation

Both sides of a licence deal benefit from agreeing the method before arguing about the number.

  • A licensor at an institution can show that the asking price reflects current readiness, and that the price steps up through milestones as risk falls. This is easier to defend inside a public institution than a single large upfront fee.
  • A licensee can argue for a lower upfront fee by pointing to the gates still ahead, while accepting higher milestone payments that are only paid if the technology succeeds.
  • Both sides can agree to revalue at each TRL step, using the same model with updated probabilities.

My view: in any negotiation over a technology below TRL 6, rNPV with stated probabilities produces better conversations than a single rate. It turns "your rate is too high" into "we think this gate is 50%, not 70%", which is a disagreement you can resolve with evidence.

Common mistakes

  • Using a mature-company cost of capital, say 12% to 15%, on a TRL 3 forecast with no probability adjustment.
  • Counting risk twice: a high discount rate and success probabilities together.
  • Quoting a rate with no sensitivity table, so the reader cannot see how much the answer depends on it.
  • Rating the TRL generously and then choosing the rate from the generous level.
  • Forgetting that development costs come first and drive the value negative at high rates.

Where does TRL Pro fit?

The weakest input in most of these models is the TRL itself, because it is self-assessed. TRL Pro assesses technology readiness from TRL 1 to 9 using Zernyx's own copyrighted framework (ZTRAF) across more than 60 technology domains and subdomains: you describe where your technology stands and get back an assessed TRL, which you can then use to anchor the rate and the gate probabilities. Buyers comparing technologies before they value one can shortlist on Zernyx Hub.

Common questions

What discount rate should I use for an early-stage technology?

There is no published Indian standard for technology discount rates by TRL. Valuers choose a rate from the cost of capital plus a premium for technical and market risk, and the premium falls as readiness rises. Whatever rate you pick, write down why, and show how the value changes at rates either side of it.

What is the difference between a risk-adjusted discount rate and rNPV?

A risk-adjusted discount rate puts all the risk into one high rate applied to the full forecast. Risk-adjusted NPV (rNPV) discounts at a lower base rate and multiplies each year's cash flow by the probability of reaching that stage. rNPV shows where the risk sits; a single rate is simpler to explain.

Why does the value go negative at high discount rates?

Development costs come first and are discounted little, while income comes years later and is discounted heavily. At a high enough rate the early costs outweigh the discounted income. In our illustration that happens at about 60%.

Does TRL alone decide the discount rate?

No. TRL measures technical maturity. Market risk, regulatory path, the strength of the patent and the team all matter too. Use TRL to anchor the technical part of the risk premium, then adjust for the rest and say so.

Sahil Sheikh
About the author

Sahil Sheikh, Regd. Patent & Trademark Agent, cRTTP

Chief IP & Technology Officer, Zernyx Innovations

Connect on LinkedIn

Know your TRL before a reviewer asks.

Run a guided, evidence-backed TRL 1 to 9 assessment with TRL Pro, ready for funding, licensing and commercialization decisions.

Assess with TRL Pro

Keep reading

Looking for something else?